Patwari A K
Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi.
Indian J Pediatr. 1999;66(1 Suppl):S63-70.
Current epidemiological scenario of Hp in India does not very clearly predict the natural history of this infection in children as they grow old. Positive serology does not seem to be of much clinical significance. Colonization by Hp in the stomach or duodenum per se does not predict a potential ulcer disease in all the cases. Most case control studies from India do not suggest any significant relationship of Helicobacter pylori (Hp) infection and recurrent abdominal pain. A significant relationship has been observed between Hp infection and antral gastritis and duodenitis. Hp related gastric or duodenal ulcers are infrequently reported in children probably because children between 12-18 years of age are not included in most of these studies. Scarce information is available regarding the relationship of Hp infection with failure to thrive, persistent diarrhea, disabled and neurodevelopmentally retarded children and the implications of acquiring infection in infancy. There is an urgent need to have guidelines for management of children with variable spectrum of gastroduodenal disease who are detected to have Hp colonization without any evidence of mucosal inflammation. Since a large number of children fall in this group, treating all of them in the absence of knowing their PCR amplified DNA sequence in Hp genome is impractical and may not be necessary. The ones detected to have evidence of mucosal inflammation attributed to Hp infection may need to be treated since it is not justified to leave these children untreated even after making a definite diagnosis. Secondly, eradication therapy may provide them the much desired symptomatic relief which is the patient's primary concern. For older children with peptic ulcer disease, using adult model for clinical significance and therapeutic options is justified. However, at present, there are no definite guidelines regarding the combinations and duration of antibacterial therapy for children in our setting due to lack of available data.
印度幽门螺杆菌(Hp)的当前流行病学情况并不能非常清晰地预测这种感染在儿童成长过程中的自然病程。血清学阳性似乎没有太大的临床意义。胃或十二指肠中Hp的定植本身并不能在所有病例中预测潜在的溃疡疾病。印度的大多数病例对照研究并未表明幽门螺杆菌(Hp)感染与复发性腹痛之间存在任何显著关系。已观察到Hp感染与胃窦炎和十二指肠炎之间存在显著关系。Hp相关的胃或十二指肠溃疡在儿童中很少见,可能是因为大多数此类研究未纳入12至18岁的儿童。关于Hp感染与发育不良、持续性腹泻、残疾及神经发育迟缓儿童的关系以及婴儿期感染的影响,现有信息匮乏。迫切需要针对检测出有Hp定植但无任何黏膜炎症证据的不同类型胃十二指肠疾病患儿制定管理指南。由于大量儿童属于这一群体,在不了解其Hp基因组PCR扩增DNA序列的情况下对他们全部进行治疗是不切实际的,而且可能没有必要。检测出有归因于Hp感染的黏膜炎症证据的患儿可能需要接受治疗,因为即使在明确诊断后仍让这些儿童不接受治疗是不合理的。其次,根除治疗可能会为他们提供迫切需要的症状缓解,这是患者的主要关注点。对于患有消化性溃疡疾病的大龄儿童,采用成人的临床意义和治疗选择模式是合理的。然而,目前由于缺乏可用数据,在我们的环境中尚无关于儿童抗菌治疗组合和疗程的明确指南。